These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34109534)

  • 1. Drug delivery for fighting infectious diseases: a global perspective.
    Loretz B; Oh YK; Hudson S; Gu Z; Lehr CM
    Drug Deliv Transl Res; 2021 Aug; 11(4):1316-1322. PubMed ID: 34109534
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases.
    He S; Leanse LG; Feng Y
    Adv Drug Deliv Rev; 2021 Nov; 178():113922. PubMed ID: 34461198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious disorders drug targets--an arsenal of knowledge on pathogen targets.
    Tekwani BL
    Infect Disord Drug Targets; 2008 Mar; 8(1):46-7. PubMed ID: 18473906
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanomedicines for Infectious Diseases.
    Dube A
    Pharm Res; 2019 Mar; 36(4):63. PubMed ID: 30859326
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymeric therapeutic delivery systems for the treatment of infectious diseases.
    Aderibigbe BA
    Ther Deliv; 2017 Jul; 8(7):557-576. PubMed ID: 28633590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon nanotubes in drug delivery: focus on infectious diseases.
    Rosen Y; Elman NM
    Expert Opin Drug Deliv; 2009 May; 6(5):517-30. PubMed ID: 19413459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool.
    Thakur K; Sharma G; Singh B; Katare OP
    Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine and infectious diseases.
    Bragg RR; Kock L
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):359-61. PubMed ID: 23566145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological barriers--Advanced drug delivery, in vitro modelling, and their implications for infection research.
    Schneider M; Loretz B; Windbergs M; Schneider-Daum N; Schaefer UF; Lehr CM
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):1-2. PubMed ID: 26259783
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential impact of nanotechnology on the control of infectious diseases.
    Allaker RP; Ren G
    Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):1-2. PubMed ID: 17706258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance: a growing problem.
    Peet NP
    Drug Discov Today; 2010 Aug; 15(15-16):583-6. PubMed ID: 20434584
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustainable therapies by engineered bacteria.
    Álvarez B; Fernández LÁ
    Microb Biotechnol; 2017 Sep; 10(5):1057-1061. PubMed ID: 28696008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational biology approaches for selecting host-pathogen drug targets.
    Brown JR; Magid-Slav M; Sanseau P; Rajpal DK
    Drug Discov Today; 2011 Mar; 16(5-6):229-36. PubMed ID: 21277381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytic Transport as a Drug Target in Infectious Diseases.
    Wong SP; Vieira A
    Infect Disord Drug Targets; 2018; 18(1):11-14. PubMed ID: 28464777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance: A multifaceted problem with multipronged solutions.
    Gil-Gil T; Laborda P; Sanz-García F; Hernando-Amado S; Blanco P; Martínez JL
    Microbiologyopen; 2019 Nov; 8(11):e945. PubMed ID: 31724836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetite nanostructures as novel strategies for anti-infectious therapy.
    Liakos I; Grumezescu AM; Holban AM
    Molecules; 2014 Aug; 19(8):12710-26. PubMed ID: 25140449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases.
    Rodrigues GR; López-Abarrategui C; de la Serna Gómez I; Dias SC; Otero-González AJ; Franco OL
    Int J Pharm; 2019 Jan; 555():356-367. PubMed ID: 30453018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal antibiotics for the treatment of infectious diseases.
    Alhariri M; Azghani A; Omri A
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-pulse drug delivery systems: setting a new paradigm for infectious disease therapy.
    Saigal N; Baboota S; Ahuja A; Ali J
    Expert Opin Drug Deliv; 2009 Apr; 6(4):441-52. PubMed ID: 19382885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases.
    Arish M; Husein A; Kashif M; Saleem M; Akhter Y; Rub A
    Drug Discov Today; 2016 Jan; 21(1):133-142. PubMed ID: 26456576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.